NWZMX
Price
$21.82
Change
+$0.01 (+0.05%)
Updated
Sep 5 closing price
Net Assets
222.47M
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
332.38B
Interact to see
Advertisement

NWZMX vs RGEBX

Header iconNWZMX vs RGEBX Comparison
Open Charts NWZMX vs RGEBXBanner chart's image
Nationwide Loomis All Cap Gr R6
Price$21.82
Change+$0.01 (+0.05%)
VolumeN/A
Net Assets222.47M
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets332.38B
NWZMX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NWZMX vs. RGEBX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NWZMX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. NWZMX (222M). NWZMX (0.00) and RGEBX (0.00) have matching dividends . NWZMX was incepted earlier than RGEBX: NWZMX (8 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than NWZMX (0.91). RGEBX is a more actively managed with annual turnover of: 25.00 vs. NWZMX (8.16). RGEBX has a lower initial minimum investment than NWZMX: RGEBX (250) vs NWZMX (1000000). NWZMX annual gain was more profitable for investors over the last year : 20.55 vs. RGEBX (17.59). RGEBX (38.71) and NWZMX (38.45) have equivalent 5 years return.
NWZMXRGEBXNWZMX / RGEBX
Total Expense Ratio0.821.0975%
Annual Report Gross Expense Ratio0.911.0983%
Fund Existence8 years11 years-
Gain YTD13.23315.39886%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets222M332B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year20.5517.59117%
Returns for 3 years70.0757.61122%
Returns for 5 years38.4538.7199%
Returns for 10 yearsN/A91.44-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
DNLI15.430.64
+4.33%
Denali Therapeutics
DOCS69.340.82
+1.20%
Doximity
SNDA25.80-0.03
-0.12%
Sonida Senior Living
CETX0.89N/A
-0.12%
Cemtrex In